Drug recall · July 8, 2026
TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recall
Why: CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.
- Lots / codes
Lot #: BL3435, Exp. 11/06/26
- Quantity
- 519 - 1 oz bottles
- Company
- Blaine Labs Inc, Santa Fe Springs, CA
- Distribution
- Nationwide in the USA
- Initiated
- April 8, 2026 · Voluntary: Firm initiated
- Classified
- July 16, 2026
- Reported
- July 8, 2026
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Benzalkonium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.